Related Experiment Videos
Perdeuteration of methoxyflurane reduces production of fluorometabolites in mice
1Department of Oral Biology, School of Dentistry, Medical College of Georgia, Augusta 30912.
Abstract:
The fluorometabolites of perdeuterated methoxyflurane (D-MOF) compared to the nondeuterated form (H-MOF) were studied in mice. Inorganic fluoride (F) and an organic acid labile fluorometabolite (OALF) were determined at various post-administration times. At 100 minutes after D-MOF, F was decreased 32-38% and OALF was down to 33-45%. After 300 minutes F was 56% less and OALF was 46% less after D-MOF administration. OALF increased 35-38% when H-MOF and D-MOF were diluted in oil compared to the undiluted forms. At three times (10, 30, and 100 minutes) D-MOF resulted in reductions of F to 31-38% of values produced by H-MOF. Also, OALF was reduced to 38-46% with D-MOF compared to H-MOF. These studies suggest that the use of D-MOF in mice results in a significant decrease in the appearance of the fluorometabolites F and OALF. The accumulation of metabolites is thought to be responsible for nephrotoxicity of MOF; therefore, D-MOF should be a much safer agent for use in general anesthesia.
Insights
Perdeuterated methoxyflurane (D-MOF) significantly reduced fluorometabolites inorganic fluoride (F) and organic acid labile fluorometabolite (OALF) in mice. D-MOF shows potential as a safer anesthetic agent due to decreased metabolite accumulation.
Area of Science:
- Anesthesiology
- Pharmacology
- Toxicology
Background:
- Methoxyflurane (MOF) anesthesia is associated with nephrotoxicity.
- Metabolite accumulation, specifically inorganic fluoride (F) and organic acid labile fluorometabolite (OALF), is implicated in MOF-induced toxicity.
- Perdeuterated methoxyflurane (D-MOF) was developed as a potential alternative to nondeuterated MOF (H-MOF).
Purpose of the Study:
- To compare the formation of fluorometabolites (F and OALF) between D-MOF and H-MOF in a mouse model.
- To evaluate the impact of deuteration on the metabolic profile of methoxyflurane.
- To assess the potential for D-MOF to reduce MOF-associated toxicity.
Main Methods:
- Mice were administered either D-MOF or H-MOF.
- Concentrations of inorganic fluoride (F) and organic acid labile fluorometabolite (OALF) were measured at various time points post-administration (10, 30, 100, and 300 minutes).
- The effect of diluting MOF in oil on metabolite levels was also investigated.
Main Results:
- D-MOF administration resulted in significant reductions in both F (31-38% at 100 min, 56% at 300 min) and OALF (33-45% at 100 min, 46% at 300 min) compared to H-MOF.
- Reductions in F and OALF were consistently observed across multiple time points.
- Dilution of MOF in oil led to a 35-38% increase in OALF for both D-MOF and H-MOF.
Conclusions:
- Perdeuterated methoxyflurane (D-MOF) significantly decreases the formation of key fluorometabolites (F and OALF) in mice compared to nondeuterated methoxyflurane (H-MOF).
- The reduced accumulation of these metabolites suggests that D-MOF may be a safer anesthetic agent with a lower risk of nephrotoxicity.
- Further investigation into D-MOF as a general anesthetic is warranted based on these findings.